Percutaneous Cryoablation is a minimally invasive, image-guided treatment that destroys (ablates) tumors and other targeted tissue with extreme cold while sparing surrounding healthy tissue. Here are some frequently asked questions about percutaneous cryoablation: What does percutaneous cryoablation mean? Percutaneous means inserted through the skin, as in placing a cryoprobe through the skin. Cryoablation comes from two ancient words: Cryo is the Greek word for cold and ablation is the Latin word for destroying tissue. In other words, percutaneous cryoablation means destroying tissue with extreme cold by inserting a probe through the skin.
After anesthesia or conscious sedation is administered, one or more cryoprobes (slender needles) are inserted into or near the tumor. The doctor uses CT or ultrasound imaging scans to guide placement and verify that the cryoprobe tip is precisely positioned. Once each cryoprobe is in place, a cryogen (freezing agent such as Argon) is circulated inside the probe to create a very cold ice ball at the tip. The ice ball encompasses (engulfs) the entire tumor plus a safety margin beyond the tumor edges, which is verified by a CT or Ultrasound scan. Once this is accomplished, I will then warm and remove the cryoprobe(s).
Lethal ice destroys tumors with a combination of effects. Basically, freezing dries out cells and damages them beyond repair. It ultimately cuts off the tumor’s blood supply. It leaves behind harmless tissue that is absorbed by the body over time. There will still be some dead tissue left behind as this is now considered a scar.
Freezing is a natural process that is typically well tolerated by the body. Typically, cryoablation causes less pain during and after the procedure compared to heat-based treatments such as radiofrequency ablation and recovery time is shorter than for surgery. While no treatment comes with a guarantee of success, a distinctive feature of cryoablation is its repeatability, if required.
As with any medical procedure, there are potential risks and complications to percutaneous cryoablation. Bleeding, infection, inflammation.
Remember: This information is provided for general information purposes only. It is not intended to constitute medical advice. Be sure to ask your doctor any questions you have and always be sure to follow your doctor’s advice.
Cryotherapy is an alternative cancer treatment when surgical removal of a tumor may be difficult or, for some patients, impossible. But its long-term effectiveness is still being examined. Currently, little published data deal with the long-term results of percutaneous cryotherapy but long-term follow-up for prostate cancer suggests cancer-control rates are similar to surgery or radiation therapy. Cryotherapy is considered a localized therapy. It can only treat disease at a single site.
Because physicians treat the tumors they see on radiologic images, microscopic cancer may be missed.
Follow up imaging, circulating tumor cells and cancer markers should be performed in 30-90 days to evaluate the success of the procedure. Sometimes retreatment is necessary due to the aggressiveness of the tumor, if there is lymph node involvement, metastases or hidden cancer stem cells which may no longer be quiescent.
Although its use in the bone, kidney, liver and lung is promising, percutaneous cryotherapy research is ongoing to determine longer term clinical outcomes.
The standard of care for the treatment of cancer is surgery, radiation and chemotherapy.
Therefore; most insurance companies consider cryoablation investigational or “experimental”. I believe in cryotherapy with immunotherapy. I foresee this form of tumor ablation to be the future of cancer treatment. If you have an aggressive tumor or multiple tumors you may have to return for multiple procedures. I only cryoablate tumors. I cannot see cancer cells therefore I cannot cryoablate cancer cells.
I cannot predict how your tumor will respond after any form of cryoablation of your tumor. It is a process. Individuals who are the most successful in interventional oncology treatments are those individuals who come in with an early diagnosis, have a single tumor, less aggressive tumor, willing to work hard and hit the tumor from many different perspectives and finally;
Have a Great attitude and willing to fight this disease.
Adrenal, bladder, bone, breast, cervix, endometrium, kidney, liver, lung, liver, lymph nodes, ovarian, pancreas, pelvic, prostate, testicular, uterine and vaginal tumors.
Percutaneous cryoablation is often used to treat adrenal, bladder, bone, breast, cervix, endometrium, kidney, liver, lung, liver, lymph nodes, ovarian, pancreas, pelvic, prostate, testicular, uterine and vaginal tumors kidney, lung and liver tumors.
In kidneys, clinical data shows nearly 100% efficacy for tumors up to 4 centimeters in diameter.
Painful bone metastases as part of palliative care: Some bone metastases (cancer that spreads to other parts of the body) become painful because the tumor attacks the bone and creates holes that make the bone thin and weak. As the tumor overtakes the bones, surrounding nerve endings send pain signals to the brain. Cryoablation can be used as a palliative (non-curative) treatment to reduce this pain.
Nerve tissue in pain management: Cryoablation freezes nerves to provide relief from chronic nerve pain. Cryoablation stops the pain signal by physically damaging the nerve. Nerves are coated by sheaths of basic proteins called myelin. Without this protective outer layer, the nerve can’t communicate with the brain. Freezing the nerve actually destroys that myelin coating.
Freezing painful nerves after chest surgery has shown to significantly reduce pain scores and maintain this effect for weeks to months.
When limbs have to be amputated, nerve endings at the amputation site can sometimes continue to send pain signals to the brain, making the person still feel pain as if the limb were still there (phantom limb pain).
Image-guided percutaneous nerve cryoablation may also be a feasible treatment for this pain.
Almost any adult with an unresectable (non-operable) tumor that requires treatment may be a candidate for percutaneous cryoablation. Except cancer involving the head and neck.
Because many patients can be treated under conscious sedation, patients who cannot receive general anesthesia may also be excellent candidates for cryoablation.
Patients with extensive metastatic disease may be candidates for cryoablation.
How long does the procedure take? A typical percutaneous cryoablation procedure takes about 1 1/2–2 hours.
When an ablation is performed in the region of an adrenal gland, it is necessary to monitor blood pressure continuously through the use of a radial arterial catheter to recognize and treat a rapid increase in blood pressure resulting from ablation of adrenal tissue. Use of these additional forms of hemodynamic monitoring should be reported. Women should always inform their physician and x-ray technologist if there is any possibility that they are pregnant. Many imaging tests are not performed during pregnancy so as not to expose the fetus to radiation. If an x-ray is necessary, precautions will be taken to minimize radiation exposure to the baby.
If the procedure is complicated due to the size and location of the tumor a short, overnight hospital stay after cryotherapy of deep tumors may be required.
Percutaneous cryotherapy can be performed as an outpatient service. I will determine this after the procedure.
You should plan to have a relative or friend drive you home after your procedure. You may be asked to wear a gown during the procedure.
Nothing to eat or drink after midnight the day before your procedure. Only take medication by mouth which is necessary such as blood pressure or diabetes medication. No blood thinners 72 hours prior to a procedure. Patients who are taking certain medications, such as blood thinners, may be required to stop several days prior to the procedure. What to bring with you will vary for each person.
Nothing to eat or drink after midnight the day before your procedure. Only take medication by mouth which is necessary such as blood pressure or diabetes medication. No blood thinners 72 hours prior to a procedure. Patients who are taking certain medications, such as blood thinners, may be required to stop several days prior to the procedure. What to bring with you will vary for each person.
After anesthesia or conscious sedation is administered, one or more cryoprobes (slender needles) are inserted into or near the tumor. The doctor uses CT or ultrasound imaging scans to guide placement and verify that the cryoprobe tip is precisely positioned. Once each cryoprobe is in place, a cryogen (freezing agent such as Argon) is circulated inside the probe to create a very cold ice ball at the tip. The ice ball encompasses (engulfs) the entire tumor plus a safety margin beyond the tumor edges, which is verified by a CT or Ultrasound scan. Once this is accomplished, I will then warm and remove the cryoprobe(s).
Typically, after the procedure you will be taken to a recovery area where you will be monitored for a certain period of time. If your procedure requires you to stay overnight, you will be taken to your room once you can be safely moved. Otherwise, you may be allowed to go home the same day.
Most patients may resume their normal routine in a day or two dependent.
While each person is different, most patients recover quickly. Typically, patients go home the same day. Most patients make a full recovery within a week or so.
However, as with any medical procedure, there are risks, and you should always closely follow your doctor’s advice.
I will schedule a CT, MRI or Ultrasound scan shortly after the procedure either 30-90 days. Follow-up CT or ultrasound scans may also be used to monitor your progress over time.
Adrenal, bladder, bone, breast, cervix, endometrium, kidney, liver, lung, liver, lymph nodes, nerve, ovarian, pancreas, pelvic, prostate, testicular, uterine, and vaginal tumors.
Lethal ice destroys tumors with a combination of effects. Basically, freezing dries out cells and damages them beyond repair. It leaves behind harmless tissue that is absorbed by the body over time; however scar tissue inside the body will remain. Cryotherapy uses argon gas to create extremely cold temperatures to destroy diseased tissue. Tumors located below the skin surface and deep in the body, I use image-guidance to insert one or more cryoprobes, through the skin to the site of the diseased tissue or tumor and then deliver the argon gas. Living tissue, healthy or diseased, cannot withstand extremely cold conditions and will die from:
Ice formation in the fluid outside cells, which results in cellular dehydration. Ice formation within the cell. At approximately -40°C (-40°F) or less, intracellular lethal ice crystals begin to form and will destroy almost any cell.
Bursting from both swelling caused by ice expansion inside the cell or shrinking caused by water exiting the cell.
Loss of blood supply. Cells die when their blood supply is choked off by ice forming within small tumor blood vessels, causing clotting. Since the average blood-clotting time is approximately 10 minutes, the extreme cold is maintained for at least 10-15 minutes, if not longer, to assure that lethal-ice temperatures have been reached. Direct observation of the ablation temperature is possible with some apparatuses. Because cryotherapy consists of a series of steps that lead to cell death, tumors are repeatedly frozen and thawed; typically, two or more freeze-thaw cycles are used depending on the location of the tumor and size of the tumor.
Once the cells are destroyed, the white blood cells of the immune system work to clear out the dead tissue. The tumor will not completely disappear but becomes a dead tumor and/or scar.
Your physician can best answer that question, but a typical percutaneous cryoablation procedure takes about 1 1/2–2 hours.
For deeper treatments involving tumors, patients should avoid blood thinning medications for the recommended period of time before the treatment. You do not have to stop any other medications.
You should report to your doctor all medications that you are taking, including herbal supplements, and if you have any allergies, especially to local anesthetic medications, general anesthesia or to contrast materials containing iodine (sometimes referred to as “dye” or “x-ray dye”). I may advise you to stop taking aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs) or blood thinners for a specified period of time before your procedure.
Image-guided ablation of benign and metastatic tumors involving bone and metastatic soft tissue tumors may be performed with the use of general anesthesia or moderate sedation. The method of anesthesia or type of sedation must be recorded.
All patients require hemodynamic monitoring in compliance with national hospital accreditation standards and local institutional standards.
In this procedure, ultrasound or computed tomography (CT) imaging, a cryoprobe may be used. Ultrasound scanners consist of a console containing a computer and electronics, a video display screen, and a transducer that is used to do the scanning. The transducer is a small hand-held device that resembles a microphone, attached to the scanner by a cord. Some exams may use different transducers (with different capabilities) during a single exam. The transducer sends out high-frequency sound waves (that the human ear cannot hear) into the body and then listens for the returning echoes from the tissues in the body. The principles are similar to sonar used by boats and submarines. The ultrasound image is immediately visible on a video display screen that looks like a computer or television monitor. The image is created based on the amplitude (loudness), frequency (pitch), and time it takes for the ultrasound signal to return from the area within the patient that is being examined to the transducer (the device placed on the patient’s skin to send and receive the returning sound waves), as well as the type of body structure and composition of body tissue through which the sound travels.
A small amount of gel is put on the skin to allow the sound waves to travel from the transducer to the examined area within the body and then back again.
Ultrasound is an excellent modality for some areas of the body while other areas, especially air-filled lungs, are poorly suited for ultrasound.
The CT scanner is typically a large, box-like machine with a hole, or short tunnel, in the center. You will lie on a narrow examination table that slides into and out of this tunnel. Rotating around you, the x-ray tube and electronic x-ray detectors are located opposite each other in a ring, called a gantry. The computer workstation that processes the imaging information is located in a separate control room, where the technologist operates the scanner and monitors your examination in direct visual contact and usually with the ability to hear and talk to you with the use of a speaker and microphone. The traditional MRI unit is a large cylinder-shaped tube surrounded by a circular magnet. You will lie on a moveable examination table that slides into the center of the magnet. The computer workstation that processes the imaging information is located in a separate room from the scanner.
Cryotherapy to treat tissue located inside the body requires image guidance and a cryotherapy applicator or cryoprobe, a thin wand-like device with a handle or trigger, or a series of small needles. The cryoprobe is connected via tubing to a source of nitrogen or argon. Most cryotherapy units use argon gas and are approved by the U.S. Food and Drug Administration (FDA). The cryotherapy system is generally housed in the procedure room. It has a computer that can be used to control the flow of the cooling agent, which is typically stored in nearby gas tanks. Other equipment that may be used during the procedure includes an intravenous line (IV), ultrasound machine, and devices that monitor your heartbeat and blood pressure.
You will be connected to monitors that track your heart rate, blood pressure, and pulse during the procedure. A nurse or technologist will insert an intravenous (IV) line into a vein in your hand or arm so that sedative medication can be given intravenously. Moderate sedation may be used. As an alternative, you may receive general or regional anesthesia. The area where the applicators or cryoprobe are to be inserted will be shaved, sterilized, and covered with a sterile drape.
A very small skin incision is made at the site. Using imaging guidance, I will insert one or more applicators or cryoprobes through the skin to the site of the diseased tissue. Once the applicators or cryoprobe(s) are in place, the argon gas is delivered. Aside from the cryoprobe(s), nothing else enters the body. An “ice ball” is created by a rapid decrease in the temperature at the tip of the probe. This causes all water in the area around the tip of the probe to freeze. Imaging is used to guide the placement of the applicators, and monitor the freezing process. The “ice ball” can be visualized using ultrasound, CT, or MRI. Some tumors require multiple applicators to freeze completely. For prostate cancer, six to eight applicators are inserted through the perineum (the tissue between the rectum and the scrotum and penis) using ultrasound guidance.
At the end of the procedure, the applicator(s) are removed and pressure will be applied to stop any bleeding.
The opening in the skin is covered with a bandage. Typically, no sutures are needed. Your intravenous line will be removed.
The entire procedure is usually completed within one to three hours.
For percutaneous cryotherapy, the patient may stay overnight or be released several hours after the procedure. Overnight stays for pain control are usually not needed. • Percutaneous cryotherapy is less traumatic than open surgery since only a small incision ¼ cm in size is needed to pass the probe through the skin, which limits damage to healthy tissue. Consequently, percutaneous cryotherapy is less costly and results in fewer side effects than open surgery.
A patient usually can resume activities of daily living 24-72 hours after the procedure depending on the location of the tumor, if not sooner. However, caution about heavy lifting may extend for several days after abdominal treatment.
For treatment of fibroadenomas, cryotherapy causes minimal scar tissue and no apparent post-treatment calcifications.
Like any percutaneous procedure, bleeding may result—both from the puncture and the freezing of tissues such as the liver, kidney, or lung.
Damage to normal structures may occur. During liver cryotherapy, the bile ducts may be injured.
During kidney cryotherapy, the ureter or collecting system may be damaged.
The rectum may be damaged during prostate cryotherapy. Any treatment of the abdomen may result in damage to the bowel and cause a hole in the bowel, which may release bowel contents into the abdomen that can lead to potentially life-threatening infection. I take many precautions in preventing this from happening.
If freezing occurs near the diaphragm, fluid can accumulate in the space around the lungs.
If the procedure is in or near the lung, the lung may collapse. Nerve damage may result.
Completely frozen nerves can cause motor weakness or numbness in the area supplied by the nerves.
Complications related to medications, including anesthesia, administered during the procedure may occur.
Women should always inform their physician or x-ray technologist if there is any possibility that they are pregnant.
This procedure may involve exposure to x-rays. However, the radiation risk is not a major concern when compared to the benefits of the procedure.
Permanent impotence since nerves controlling sexual potency are commonly involved in the freezing process.
However, nerves can regenerate, resolving the problem in some patients. While the patient is under anesthesia, a bladder tube is positioned to drain urine until the swelling of the bladder neck—as a result of the procedure—resolves. May cause urethral sloughing; that is, blocking of the urine stream with dead tissue. Sloughing is reduced by keeping the urethra warm with sterile water circulating continuously through a catheter placed in the urethra during the procedure.
Chemo/Immuno/embolization therapy is used to treat tumors or for post surgical adjunctive treatment. Medicines are injected into organ systems through blood vessels, delivering a small local dose of cancer killing medicine directly to the tumor or tumor area. Another material called an embolic agent is also put into the blood vessels which cuts off the blood supply and essentially starves the tumor of the blood they need to survive and grow.
Using x-ray guidance, a small catheter is inserted into an artery, usually in the upper thigh region, or left wrist and fed up to the cancerous organ. Special dye is first injected which allows pictures to be taken and the vessels surrounding the tumor to be visualized. Then the medicine and/or embolic material are injected into the cancerous organ directed at the tumor.
All of the following signs are part of a normal recovery after Chemoembolization or Embolization.
Within a month after the procedure you should be back to your usual self.
Pain for the first few days to week. It may radiate to the chest, shoulder, abdomen, pelvis or back. You will be given medicine to help control the pain. This pain usually gets better within the first week.
Extreme fatigue or tiredness for two to four weeks after the procedure.
A poor appetite which may result in weight loss before your appetite returns continue to eat even if you have no appetite. Small, frequent meals are the best way to prevent weight loss.
Fevers up to 102 degrees for one to two weeks after the treatment Occasionally, hair loss may be seen (rare).
It is normal to have a bruise and soreness where the catheter entered into the artery.
Diet: There are no dietary restrictions specifically due to this procedure. If you had restrictions prior due to other treatments or diseases such as diabetes, cardiovascular disease, or renal disease, continue with these. Alcohol consumption is not recommended. Drink 6 to 8 glasses of liquid each day. It is especially important to do this if you are vomiting. Or, follow your caregiver’s advice if you must limit the number of liquids you drink. Good liquids to drink are water.
Nausea is common following this procedure.
Eat light for the first 24 hours and try to stay away from foods that trigger nausea for you.
A prescription for anti-nausea medicine will be given to you.
Activity: Expect to be tired for the first week after the procedure and gradually gain strength back. Do not plan anything active or requiring your close attention for the first few days following discharge from the hospital. If you work, two weeks of rest time should be adequate.
A responsible adult must accompany you home from the hospital. This is a facility policy for your safety
Bathing: It is okay to shower 24 hrs. after the procedure. Gently wash the catheter insertion site with soap and water, do not scrub. Do not bathe or soak in water for 3 days following the procedure. If the access site is oozing or bleeding slightly, place a small bandage over it to protect your clothes. Change the bandage if it gets wet or dirty. Once the site has stopped oozing, you may leave it open to the air.
Medications: Usually, your pre-procedure medications do not change. You will be told before discharge if any of your medicines change. The following medications will be prescribed to you upon discharge IN ADDITION to your normal medicines:
1. Phenergan(promethazine) or Zofran, an antinausea drug. Take this medication every 6 hours if you are experiencing nausea.
2. Narcotic pain medicine, usually oxycodone (generic for Percocet) or Dilaudid. Take this if you have pain, but not more frequently than every four hours
Do not drive after taking this medicine, it causes drowsiness. If the bottle says it has Acetaminophen with it, do not take additional Tylenol while taking this medication.
3. Sennakot or Dulcolax (same medicine/different name), prevents or treat constipation. Take this twice a day, morning and night, if you are taking the narcotic pain medicine or are having constipation. Probiotics also help. Such as probiomax by xymogen.
Follow Up: We recommend setting up a follow-up appointment after you are discharged from the hospital or surgery center. Every doctor is different in when they want to see their patients after treatment, but some want to see you as soon as two weeks to four weeks following.
Follow-up imaging is usually ordered and is done 1-3 months after treatment. The timing of follow-up imaging may vary depending on my preferences. If you have a question about needing an appointment or test results, please call 858-480-1977.
When to Get Medical and Emergency Help:
Call our RN triage line at 619-425-4209:
Go to your nearest Emergency Room:
I recommend Scripps Chula Vista, Scripps Encinitas, Sharp Chula Vista, Sharp Memorial Kearny Mesa or Paradise Valley Hospital.
Contact Us
Phone: (858) 480-1977
Fax: (888) 625-8230
info@strykermd.net
Mailing Address Only
153 South Sierra Avenue,
Suite 990
Solana Beach, CA, 92075
Stay up to date with Stryker MD
Thank you for contacting Dr. Stryker.
We will get back to you as soon as possible.
Privacy Policy
Terms & Conditions
All Rights Reserved | Stryker MD | Web Design by GoBeRewarded